RemSleep Holdings Inc (RMSL)

[trader59]

LOL!!!

First off, and once again, this company does not make CPAP machines, at all, they advertise to resell Chinese knockoff machines. That's important, because that means the whole narrative is completely meaningless to this company (and its stock).

Secondly, and as I stated, CPAP is mentioned in the article as a potential treatment for someone presenting with pneumonia that would be transferred to isolation for an actual COVID-19 test. That's what it says:

Patients diagnosed with viral pneumonia require isolation and SARS-CoV-2 tests (measure 3). Systemic and local respiratory defense mechanisms are compromised, resulting in bacterial co-infection if early, effective antiviral treatment is not started. Empirical therapy consists of oral moxifloxacin or levofloxacin (consider tolerance) and arbidol. Arbidol is approved in China and Russia for influenza treatment. In-vitro studies showed that arbidol had inhibitory effects on SARS.2
Patients testing positive for SARS-CoV-2 are transferred to designated hospitals.
Dyspnoea and hypoxaemia suggest severe pneumonia and are suspicious even in afebrile patients. If presenting with dyspnoea and hypoxia (oxygen saturation [SpO2] <93%), prescribe supplemental oxygen, admit to an isolation ward, and assess transfer risk. If patients are deteriorating with measure 3 interventions, the core treatment principle we recommend is antiviral plus antipneumococcus plus anti-Staphylococcus aureus (measure 4, figure). Coverage for Streptococcus pneumoniae and S aureus is important as co-infection increases the likelihood of severe illness.3
High-dose nemonoxacin (750 mg once daily) and linezolid is effective against S pneumoniae and Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus [MRSA]).
Glucocorticoids are not a routine treatment.4
In emergency cases, such as SpO2 <90%, dexamethasone 5–10 mg or methylprednisolone 40–80 mg is given intravenously before transfer. High-throughput oxygen therapy or continuous positive airway pressure (CPAP) ventilation are both effective supportive therapies and target blood SpO2 should be 88–90%. Invasive mechanical ventilation is used as a last resort.